Stay updated on Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.

Latest updates to the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedSite revision updated from v3.4.1 to v3.4.2 with no substantive changes to study details, eligibility criteria, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check15 days agoChange DetectedThe page now shows Revision: v3.4.1, and the previous government-funding notices (lapse) and Revision: v3.4.0 have been removed.SummaryDifference0.3%

- Check22 days agoChange DetectedA new informational banner about a lapse in government funding and NIH operations was added at the top of the page, with links to cc.nih.gov and opm.gov.SummaryDifference0.3%

- Check29 days agoChange DetectedThe page updates are minor UI and metadata changes: a new 'Show glossary' option, updated QC-related labels (Last Update Submitted that Met QC Criteria), a new 'No FEAR Act Data' label, and a revised version tag (Revision: v3.4.0), with the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check36 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3; no evident changes to study content or data.SummaryDifference0.0%

- Check65 days agoChange DetectedThe Locations section was expanded with new sites across Maryland, Michigan, Brussels Capital, Liege, Ontario, Bavaria, North Holland, Daegu Gwang Yeogsi, Seoul Teugbyeolsi, Barcelona, and London. The page revision was updated to v3.3.3, and older location subsections were removed.SummaryDifference1.0%

Stay in the know with updates to Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.